Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes

• Status: Completed
• Trial end date: 2004-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Insulin is a chemical that the body needs in order to use or store sugar. It is made by a type of cell called a beta cell which resides in an organ known as the pancreas. Type 1 diabetes is a disease where the beta cells have been destroyed so that little or no insulin is made. Sugar levels rise in the blood as a result. INGAP-Peptide is being tested to attempt to create new beta cells in the pancreas, and to restore the ability to produce insulin in type 1 diabetic patients.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Exsulin Corporation

Criteria

Inclusion Criteria

• Age 18-65

• fasting C-peptide <0.3 ng/ml.

• HbA1c <10%

• history of onset of type 1 DM at or before 20 years of age.

• Otherwise healthy